These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17584949)

  • 1. Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study.
    Ramsay SE; Whincup PH; Wannamethee SG; Papacosta O; Lennon L; Thomas MC; Morris RW
    J Public Health (Oxf); 2007 Sep; 29(3):251-7. PubMed ID: 17584949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antiplatelet medication in hospitalised elderly patients.
    Wawruch M; Slezakova V; Murin J; Kuzelova M; Dukat A; Zabka M; Leitmann T; Tisonova J; Kallay Z
    Bratisl Lek Listy; 2015; 116(9):533-8. PubMed ID: 26435017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study.
    Dahlgren C; Geary L; Hasselström J; Rehnberg C; Schenck-Gustafsson K; Wändell P; Euler MV
    BMJ Open; 2017 Sep; 7(9):e015723. PubMed ID: 28939569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.
    Ramsay SE; Whincup PH; Lawlor DA; Papacosta O; Lennon LT; Thomas MC; Ebrahim S; Morris RW
    BMJ; 2006 Jan; 332(7534):144-5. PubMed ID: 16401630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
    Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
    Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, sex and practice variations in the use of statins in general practice in England and Wales.
    Majeed A; Moser K; Maxwell R
    J Public Health Med; 2000 Sep; 22(3):275-9. PubMed ID: 11077897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database.
    Gibbs RG; Newson R; Lawrenson R; Greenhalgh RM; Davies AH
    Stroke; 2001 May; 32(5):1085-90. PubMed ID: 11340214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study.
    de Lusignan S; Belsey J; Hague N; Dhoul N; van Vlymen J
    J Public Health (Oxf); 2006 Dec; 28(4):361-9. PubMed ID: 17038329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis at 6 months for coronary and cerebrovascular patients: impact of antiplatelet agents and statins: results from the Prevenir III study.
    Ferrières J; Cambou JP; Cantet C; Guize L
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):55-61. PubMed ID: 16552472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women.
    Emberson JR; Whincup PH; Lawlor DA; Montaner D; Ebrahim S
    Heart; 2005 Apr; 91(4):451-5. PubMed ID: 15772196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
    Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
    Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention after stroke/transient ischemic attack: A randomized audit and feedback trial.
    Geary L; Hasselström J; Carlsson AC; Eriksson I; von Euler M
    Acta Neurol Scand; 2019 Aug; 140(2):107-115. PubMed ID: 31017305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA.
    Geary L; Aronius J; Wettermark B; Hasselström J; Sjöborg B; von Euler M
    Int J Clin Pract; 2017 Mar; 71(3-4):. PubMed ID: 28371022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
    Xian Y; Navar AM; Li S; Li Z; Robinson J; Virani SS; Louie MJ; Koren A; Goldberg A; Roger VL; Wilson PWF; Peterson ED; Wang TY
    J Am Heart Assoc; 2019 Oct; 8(19):e013229. PubMed ID: 31554462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial.
    Lv X; Liu X; Peng Y; Li W; Wang J; Chen X; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
    J Stroke Cerebrovasc Dis; 2024 May; 33(5):107647. PubMed ID: 38431112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study.
    Dalli LL; Kim J; Cadilhac DA; Greenland M; Sanfilippo FM; Andrew NE; Thrift AG; Grimley R; Lindley RI; Sundararajan V; Crompton DE; Lannin NA; Anderson CS; Whiley L; Kilkenny MF
    Stroke; 2021 Nov; 52(11):3569-3577. PubMed ID: 34315251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declining 1-year case-fatality of stroke and increasing coverage of vascular risk management: population-based cohort study.
    Gulliford MC; Charlton J; Rudd A; Wolfe CD; Toschke AM
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):416-22. PubMed ID: 20176596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.